EDAP TMS reported EUR72.06M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AngioDynamics USD 269.68M 4.04M Sep/2025
Boston Scientific USD 45.22B 865M Jun/2026
EDAP TMS EUR 72.06M 10.6M Mar/2026
Henry Schein USD 11.38B 77M Jun/2026
Medtronic USD 93.03B 1.54B Mar/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Veracyte USD 1.49B 49.97M Jun/2026